This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Abbott Laboratories(ABT) downgraded at Citigroup from Hold to Sell, Citigroup said. $44 price target. Fundamentals are sliding and costs are rising.
Amylin Pharmaceuticals(AMLN) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $20 price target. Company has reached an agreement with the FDA that reduces risk around the tQT trial.
Abercrombie & Fitch(ANF) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $57 price target. Teen space will likely see higher competition and all retailers are struggling with cotton costs.
Ann Taylor(ANN) upgraded at Citigroup from Hold to Buy, Citigroup said. $27 price target. Stock is down 20% year-to-date and LOFT sales appear to be stabilizing.
BorgWarner(BWA) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call.
Chico's FAS(CHS) upgraded at FBR from Market Perform to Outperform, FBR Capital said. $14 price target. Valuation call.
Family Dollar(FDO) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. Valuation call.
Goodyear Tire(GT) downgraded at Goldman to Neutral from Buy, Goldman Sachs said. Earnings recovery is being pushed out by higher raw materials costs.
Carmax(KMX) upgraded at RBC from Sector Perform to Outperform, RBC Capital Markets said. $37 price target.
Meredith(MDP) upgraded at Citigroup to Buy, Citigroup said. $44 price target. Company appears more confident about its long-term growth potential.
Magna(MGA) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Company is showing much better operating leverage.
Murphy Oil(MUR - Get Report) numbers lowered at Morgan Stanley. MUR estimates were cut through 2012, Morgan Stanley said. Company reduced its production guidance. Overweight rating and new $83 price target.
Murphy Oil(MUR - Get Report) downgraded at BMO to Underperform, BMO Capital Markets said. $65 price target. Company lowered it production guidance.
Netflix(NFLX - Get Report) upgraded at ThinkEquity from Hold to Buy. $220 price target. Company is seeing higher subscriber growth.
Netflix(NFLX - Get Report) upgraded at Morgan Keegan from Underperform to Market Perform, Morgan Keegan said. Company had solid earnings and is addressing margin fears.